Wendy Komocsar

Gene Expression and Pharmacodynamic Changes in 1,760 Systemic Lupus Erythematosus Patients From Two Phase III Trials of BAFF Blockade With Tabalumab

Robert W. Hoffman, Joan T. Merrill, Marta M. E. Alarcón‐Riquelme et al. · Arthritis & Rheumatology · 2016 · 72 citations · Full text

Evaluation of pneumococcal and tetanus vaccine responses in patients with rheumatoid arthritis receiving baricitinib: results from a long-term extension trial substudy

Kevin Winthrop, Clifton O. Bingham, Wendy Komocsar et al. · Arthritis Research & Therapy · 2019 · 59 citations · Full text

A qualitative study exploring the health-related quality of life and symptomatic experiences of adults and adolescents with ulcerative colitis

Louise Newton, Jason A. Randall, Theresa Hunter et al. · Journal of Patient-Reported Outcomes · 2019 · 38 citations · Full text

Immunophenotyping analysis of peripheral blood, splenic, and thymic lymphocytes in male and female rats

Dale L. Morris, Wendy Komocsar · Journal of Pharmacological and Toxicological Methods · 1997 · 35 citations

Autoimmune Disease, Allergy, Immunology +7

Efficacy and safety of tabalumab, an anti-B-cell-activating factor monoclonal antibody, in patients with rheumatoid arthritis who had an inadequate response to methotrexate therapy: results from a phase III multicentre, randomised, double-blind study

Josef S Smolen, Michael E. Weinblatt, Désirée van der Heijde et al. · Annals of the Rheumatic Diseases · 2015 · 32 citations